Pregnancy and infant outcomes following SARS-CoV-2 infection in pregnancy during delta variant predominance - Surveillance for Emerging Threats to Pregnant People and Infants
- PMID: 38135220
- PMCID: PMC11264249
- DOI: 10.1016/j.ajogmf.2023.101265
Pregnancy and infant outcomes following SARS-CoV-2 infection in pregnancy during delta variant predominance - Surveillance for Emerging Threats to Pregnant People and Infants
Abstract
Background: SARS-CoV-2 infection in pregnancy is associated with an increased risk of adverse birth outcomes such as preterm birth, stillbirth, and maternal and infant complications. Previous research suggests an increased risk of severe COVID-19 illness and stillbirth in pregnant people during delta variant predominance in 2021; however, those studies did not assess timing of infection during pregnancy, and few of them described COVID-19 vaccination status.
Objective: Using a large population-based cohort, this study compared pregnancy and infant outcomes and described demographic and clinical characteristics of pregnant people with SARS-CoV-2 infection prior to and during the delta variant period.
Study design: This retrospective cohort analysis included persons with confirmed SARS-CoV-2 infection in pregnancy from 6 US jurisdictions reporting to the Surveillance for Emerging Threats to Pregnant People and Infants Network. Data were collected through case reports of polymerase chain reaction-positive pregnant persons and linkages to birth certificates, fetal death records, and immunization records. We described clinical characteristics and compared frequency of spontaneous abortion (<20 weeks of gestation), stillbirth (≥20 weeks), preterm birth (<37 weeks), small for gestational age, and term infant neonatal intensive care unit admission between the time periods of pre-delta and delta variant predominance. Study time periods were determined by when variants constituted more than 50% of sequences isolated according to regional SARS-CoV-2 genomic surveillance data, with time periods defined for pre-delta (March 3, 2020-June 25, 2021) and Delta (June 26, 2021-December 25, 2021). Adjusted prevalence ratios were estimated for each outcome measure using Poisson regression and were adjusted for continuous maternal age, race and ethnicity, and insurance status at delivery.
Results: Among 57,563 pregnancy outcomes, 57,188 (99.3%) were liveborn infants, 65 (0.1%) were spontaneous abortions, and 310 (0.5%) were stillbirths. Most pregnant persons were unvaccinated at the time of SARS-CoV-2 infection, with a higher proportion in pre-delta (99.4%) than in the delta period (78.4%). Of those with infections during delta and who were previously vaccinated, the timing from last vaccination to infection was a median of 183 days. Compared to pre-delta, infections during delta were associated with a higher frequency of stillbirths (0.7% vs 0.4%; adjusted prevalence ratio, 1.55; 95% confidence interval, 1.14-2.09) and preterm births (12.8% vs 11.9%; adjusted prevalence ratio, 1.14; 95% confidence interval, 1.07-1.20). The delta period was associated with a lower frequency of neonatal intensive care unit admission (adjusted prevalence ratio, 0.74; 95% confidence interval, 0.67-0.82) than in the pre-delta period. During the delta period, infection during the third trimester was associated with a higher frequency of preterm birth (adjusted prevalence ratio, 1.41; 95% confidence interval, 1.28-1.56) and neonatal intensive care unit admission (adjusted prevalence ratio, 1.21; 95% confidence interval, 1.01-1.45) compared to the first and second trimester combined.
Conclusion: In this US-based cohort of persons with SARS-CoV-2 infection in pregnancy, the majority were unvaccinated, and frequencies of stillbirth and preterm birth were higher during the delta variant predominance period than in the pre-delta period. During the delta period, frequency of preterm birth and neonatal intensive care unit admission was higher among infections occurring in the third trimester vs those earlier in pregnancy. These findings demonstrate population-level increases of adverse fetal and infant outcomes, specifically in the presence of a COVID-19 variant with more severe presentation.
Keywords: COVID-19; SARS-CoV-2; adverse perinatal outcomes; delta variant; fetal death; pregnancy; preterm birth; stillbirth.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
J.M.C. disclosed previously owning Moderna stock in the amount of $800.00 at the time of sale. All the other authors report no conflict of interest.
Similar articles
-
Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study.Lancet Respir Med. 2022 Dec;10(12):1129-1136. doi: 10.1016/S2213-2600(22)00360-5. Epub 2022 Oct 7. Lancet Respir Med. 2022. PMID: 36216011 Free PMC article.
-
Reductions in stillbirths and preterm birth in COVID-19-vaccinated women: a multicenter cohort study of vaccination uptake and perinatal outcomes.Am J Obstet Gynecol. 2023 May;228(5):585.e1-585.e16. doi: 10.1016/j.ajog.2022.10.040. Epub 2022 Nov 3. Am J Obstet Gynecol. 2023. PMID: 36336084 Free PMC article.
-
COVID-19 vaccination during pregnancy: coverage and safety.Am J Obstet Gynecol. 2022 Feb;226(2):236.e1-236.e14. doi: 10.1016/j.ajog.2021.08.007. Epub 2021 Aug 10. Am J Obstet Gynecol. 2022. PMID: 34389291 Free PMC article.
-
Association of Infection with Different SARS-CoV-2 Variants during Pregnancy with Maternal and Perinatal Outcomes: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2022 Nov 29;19(23):15932. doi: 10.3390/ijerph192315932. Int J Environ Res Public Health. 2022. PMID: 36498007 Free PMC article.
-
Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2020 May;2(2):100107. doi: 10.1016/j.ajogmf.2020.100107. Epub 2020 Mar 25. Am J Obstet Gynecol MFM. 2020. PMID: 32292902 Free PMC article.
Cited by
-
PostCOVID-19 Impact on Perinatal Outcomes.Diagnostics (Basel). 2024 Dec 29;15(1):57. doi: 10.3390/diagnostics15010057. Diagnostics (Basel). 2024. PMID: 39795585 Free PMC article.
-
Decline in and recovery of fertility rates after COVID-19-related state of emergency in Japan.BMJ Open. 2024 Oct 8;14(10):e087657. doi: 10.1136/bmjopen-2024-087657. BMJ Open. 2024. PMID: 39384228 Free PMC article.
-
Prenatal Maternal Immunization for Infant Protection: A Review of the Vaccines Recommended, Infant Immunity and Future Research Directions.Pathogens. 2024 Feb 23;13(3):200. doi: 10.3390/pathogens13030200. Pathogens. 2024. PMID: 38535543 Free PMC article. Review.
-
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development.Vaccines (Basel). 2024 Dec 28;13(1):17. doi: 10.3390/vaccines13010017. Vaccines (Basel). 2024. PMID: 39852796 Free PMC article. Review.
References
-
- Strid P, Zapata LB, Tong VT, et al. Coronavirus disease 2019 (COVID-19) severity among women of reproductive age with symptomatic laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by pregnancy status-United States, 1 January 2020–25 December 2021. Clin Infect Dis 2022;75. S317–25. - PMC - PubMed
-
- Mahase E Covid-19: what do we know about omicron sublineages? BMJ 2022;376:o358. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous